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Primary cardiac sarcoma is a rare aggressive entity. It constitutes the second most common type of primary
cardiac neoplasms. Its management has largely been guided by small retrospective series with a median
survival of 6 months. Here, we discuss a unique case of 8-year survival cardiac leiomyosarcoma managed by
surgical and adjuvant therapy.
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Primary cardiac sarcomas constitute a rare entity. At
present, only a few hundred primary cardiac sarcomas
have been reported, most of which are based on autopsy
series. Despite this rarity, they are the second most com-
mon type of primary cardiac neoplasm and account for
most of the malignant primary cardiac tumors. Primary
cardiac sarcomas are aggressive tumors that generally do
not produce symptoms until they are locally advanced.
Their management has largely been guided by small
retrospective series and non-cardiac sarcoma manage-
ment principles. However, the prognosis of primary car-
diac sarcomas in general remains poor according to the
current medical literature. The median survival in patients
with cardiac sarcomas has been reported to be about
6 months with a mean of 11 months. Here, we discuss a
unique case of 8-year survival cardiac leiomyosarcoma
managed by surgical and adjuvant therapy.Case presentation
A 47-year-old man presented with acute pulmonary
edema with severe progressive dyspnea and orthopnea.
He had a 10 pack-year history of cigarette smoking, but
no other medical or familial conditions. Chest radio-
graph showed a small right-sided pleural effusion. Elec-
trocardiogram revealed sinus tachycardia without any
conduction abnormalities. Transthoracic echocardiography* Correspondence: zineb247@hotmail.com
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reproduction in any medium, provided the orand cardiac magnetic resonance imaging (CRMI) showed
a tumor (4 × 5 cm) occupying the side wall of the right
atrium budding into the lumen (Figure 1).
Through a median sternotomy, a radical excision of the
neoplasm was performed; the atrial wall was reconstructed
using a bovine pericardial patch. The post-operative course
was unremarkable and the anatomical pathology analysis
revealed fusiform cells with considerable nuclear pleo-
morphism and mitotic activity. The immunohistochemical
study was positive to vimentin, desmin, actin, and HHF-35,
and negative for PS-100, cytokeratin, and hormone recep-
tors. The final diagnosis was cardiac leiomyosarcoma.
Adjuvant chemotherapy with doxorubicin (60 mg/m2 day
1) and ifosfamide (3 g/m2 day 1 and 2) were realized and
MRI after the four cycles did not show any sign of local or
distant relapse.
Seven years after the first operation, local recurrence
with a metastatic paravertebral soft tissue mass was re-
vealed by magnetic resonance imaging. There was no
lung metastasis. The patient received antalgic vertebral
radiotherapy with systemic palliative chemotherapy con-
sisting of oral cyclophosphamide. One year later, he died
of progressive disease and multiorgan failure.Conclusions
Primary leiomyosarcomas of the heart [1] are extremely
rare, accounting for 0.019% of all malignant cardiac neo-
plasms in autopsy studies [2]. They typically occur in the
fourth decade with no sex predilection. As all other cardiac
sarcomas, primary leiomyosarcoma of the heart are usually
asymptomatic until an advanced stage. Consequently, theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Figure 1 MRI T2 cuts, minor axis passing throughout the right atrium showing an irregular isosignal wall thickening of the side wall of
the right atrium.
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consequences and embolisms. Cardiac MRI is the gold
standard complementary exam to distinguish malignant
lesions and assess the resectability of the tumors.
Due to the small series reporting this disease, the
treatment guidelines are not well defined. Radical surgi-
cal interventions seem to offer the best outcome; how-
ever, a complete surgical resection is often difficult to
achieve. The role of adjuvant chemotherapy and radio-
therapy to prolong survival in this group of patients is
not clear [3-5]. Another therapeutic option is orthotopic
heart transplantation. In this case, the work up shouldTable 1 Cases of cardiac leiomyosarcoma reported in the lit
and survival
Reference Age/sex Origin site Tumor size Grade Margin sta
[7] 64/F Left atrium 17 3 Positive
[7] 54/M Right atrium 6 3 Positive
[5] 45/F Left atrium 10 3 Positive
[8] 46/M Left ventricle – 2–3 –
[8] 42/F Left ventricle – 3 –
[9] 63/F Right ventricle 4
[10] 86/F Left atrium 4 – –
[11] 74/M Left atrium – – Positive
[12] 54/F Right atrium
[13] 35/F Right atrium 5.6 3 Positiveinclude a total body positron emission tomography and
CT scans to exclude distant metastases [6]. Thus, the
adequate multimodal treatment strategy should be dis-
cussed in a pluridisciplinary meeting in order to improve
survival. Prognosis is poor. Nevertheless, it seems that
for patients who survived the initial surgery, the pro-
spect for long-term survival is very promising. The
present case has been discussed in view of rarity of long-
term survival in cardiac leiomyosarcomas since our
patient is the longest survivor reported thus far in the
English language medical literature with good interim
quality of life (Table 1).erature with available data of treatment modalities
tus Treatment received Survival (months)
Curative surgery and adjuvant chemotherapy 9
Curative surgery and adjuvant chemotherapy 13





Curative surgery and adjuvant radiotherapy 8
Curative surgery Few hours
Surgery and palliative chemotherapy 10
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